Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
Dow
Mallinckrodt
Julphar
McKesson
McKinsey
Colorcon
QuintilesIMS

Generated: May 26, 2018

DrugPatentWatch Database Preview

ENALAPRIL MALEATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Enalapril Maleate patents expire, and when can generic versions of Enalapril Maleate launch?

Enalapril Maleate is a drug marketed by Apotex, Apothecon, Ivax Sub Teva Pharms, Krka Dd Novo Mesto, Mylan, Sandoz, Sandoz Inc, Sun Pharm Inds Ltd, Taro, Teva, Watson Labs, Wockhardt Ltd, Apotex Inc, Dr Reddys Labs Ltd, G And W Labs Inc, Taro Pharm Inds, and Upsher-smith Labs. and is included in twenty-three NDAs.

The generic ingredient in ENALAPRIL MALEATE is enalapril maleate; hydrochlorothiazide. There are twenty-seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the enalapril maleate; hydrochlorothiazide profile page.
Drug patent expirations by year for ENALAPRIL MALEATE
Pharmacology for ENALAPRIL MALEATE
Synonyms for ENALAPRIL MALEATE
((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline
(2S)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic aci
(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid; maleic acid
(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid
(S,S,S)-1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
(S,S,S)-Enalapril Maleate
(S)-(-)-1-[N-(1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl]-Lproline
(S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-((R)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID MALEATE
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate
(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline maleate (1:1)
(S)-1-[(R)-2-((R)-1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
(S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-AL
(S)-1-[N-[1-(ETHOXYCARBONXYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE
(S)-1-[N-[1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE
(S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
(S)-N-[1-(Ethoxycarbonyl)-3-phenylpropyl]-Ala-Pro maleate salt
(SSS)1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
(Z)-but-2-enedioic acid; (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
095E164
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester, maleate (1:1)
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid (Enalapril)
1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(enalapril)
1-[N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-L-proline Maleate
172964-46-4
2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid(enalapril)
69PN84IO1A
75847-73-3
75847-73-3 (Parent)
76095-16-4
76095-16-4 (maleate)
76420-75-2
77549-58-7
77549-59-8
847E733
9O25354EPJ
A-Rin
AB00053615_19
AB00053615_20
AB00053615-17
AB00053615-18
AB0013100
AB03713
AB2000386
AC1NTUS2
AC1NTUS5
Acetensil
AK325516
AK486954
AKOS016340376
AKOS025310615
Alphrin
Amprace
AN-15422
analapril
Analept
AOB5651
API0002541
Atens
Baripril
BDBM50017129
Benalapril
Benalipril
BIDD:GT0751
Biocronil
BPBio1_000340
BQL
BSPBio_000308
BSPBio_003035
C-21264
C06977
C20H28N2O5
C20H28N2O5.C4H4O4
CAS-75847-73-3
CAS-76095-16-4
CC-27456
CCG-39221
CHEBI:4784
CHEBI:4785
CHEMBL1200659
CHEMBL578
Controlvas
Converten
Convertin
Coprilor
Coroldil
CPD001906771
Crinoren
CS-2373
CS-2918
CTK8F9436
D00621
D00SEB
D07892
Dabonal
DB00584
Defluin
Denapril
Ditensor
DivK1c_000408
DR002110
DSSTox_CID_2982
DSSTox_GSID_22982
DSSTox_RID_76817
DTXSID5022982
Ecapril
Ednit
Ednyt
EINECS 278-375-7
EINECS 278-460-9
Elfonal
Enacard
Enalabene
Enaladex
Enaladil
enalapril
Enalapril (INN)
Enalapril (maleate)
Enalapril (TN)
Enalapril [INN:BAN]
ENALAPRIL 2-BUTENEDIOATE
enalapril hydrogen maleate
Enalapril maleate (JP17/USP)
Enalapril maleate (Vasotec)
Enalapril maleate [USAN:JAN]
Enalapril maleate [USAN:USP:JAN]
Enalapril maleate salt
Enalapril Maleate Usp Xxi
Enalapril Richet
Enalapril, AldrichCPR
Enalaprila
Enalaprila [INN-Spanish]
Enalaprilmaleate
Enalaprilum
Enalaprilum [INN-Latin]
Enalasyn
Enaloc
Enalped
Enap
Enapren
Enapres
Enapril
Enaprin
Enarenal
Enaril
Envas
Epaned
Epaned Kit
Eupressin
Feliberal
GBXSMTUPTTWBMN-XIRDDKMYSA-N
Glioten
Glioten;Renitec;Vasotec
GTPL6322
H531
HE386417
Herten
Hipoartel
Hipten
HMS1921B10
HMS2090E08
HMS2092L17
HMS2095P10
HMS2231D22
HMS2232I24
HMS501E10
HSDB 6529
HY-B0331
HY-B0331A
Hytrol
I04-153
IDI1_000408
Innovace
Innovace Melt
Innovade
Inoprilat
Insup
Invoril
J10412
K298
KBio1_000408
KBio2_001787
KBio2_004355
KBio2_006923
KBio3_002535
KBioGR_000355
KBioSS_001787
Kenopril
KM1738
Konveril
KS-1137
L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-
L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-, (Z)-2-butenedioate (1:1)
L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-
L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-, (2Z)-2-butenedioate (1:1)
L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-
Lapril
Lipraken
Lotrial
LS-118938
LS-190651
Mapryl
Mepril
MFCD00133304
MFCD00865774
Minipril
MK 421
MK 421 maleate
MK-421
MLS000028657
MLS001077272
MLS006010047
MolPort-002-885-877
MolPort-003-666-389
N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate (1:1)
N-(1 (S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate
N-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline
N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline maleate
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline
N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline (2Z)-but-2-enedioate
N-[(S)-1-ETHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE MALEATE(1: 1)
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
N-[1(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline maleic acid salt
N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline
N-{N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl}-L-proline hydrogen maleate
Nalpha -[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline
Naprilene
Naritec
NCGC00016932-01
NCGC00021569-04
NCGC00021569-05
NCGC00021569-06
NCGC00021569-09
Neotensin
NINDS_000408
Norpril
NSC-758143
NSC758143
Nuril
Opera_ID_1793
OYFJQPXVCSSHAI-QFPUQLAESA-N
Palane
Pharmakon1600-01501214
Pres
Presil
Pressotec
Prestwick_197
Prestwick3_000314
Pril
Prilenap
PRO106
Pulsol
Reca
Regomed
Renavace
Renitec
Reniten
Renivace
Renivace (TN)
Repantril
Ristalen
s1941
SAM002564252
SBI-0051691.P002
SC-17520
SC-76440
SCHEMBL18
SCHEMBL9
Sintec
SMR000058883
SMR000653477
SPBio_001349
Spectrum_001307
SPECTRUM1501214
Spectrum2_001455
Spectrum3_001478
Spectrum4_000008
Spectrum5_001107
SR-01000000234
SR-01000000234-4
ST51052621
Tenace
Tensazol
Tox21_110872
Tox21_110872_1
Unaril
UNII-69PN84IO1A
UNII-9O25354EPJ
Vapresan
Vasopril
Vasotec
Xanef
ZINC3791297

US Patents and Regulatory Information for ENALAPRIL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075657-001 Jan 23, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075621-002 Aug 22, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ENALAPRIL MALEATE enalapril maleate TABLET;ORAL 075501-001 Aug 22, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075909-002 Oct 15, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Cantor Fitzgerald
Baxter
Fish and Richardson
Moodys
Deloitte
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.